The results of the animal model suggest that overexpression of VCP significantly promoted tumor size and weight in the subcutaneous xenograft and orthotopic transplantation models, and, crucially, the promoting effect of VCP was significantly limited after the downregulation of FASN or USP2, respectively (Fig. 8A). The gene discussed is USP2; the disease is neoplasm.